<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05117827</url>
  </required_header>
  <id_info>
    <org_study_id>22-052-H</org_study_id>
    <nct_id>NCT05117827</nct_id>
  </id_info>
  <brief_title>Pediatric Powered Wheelchair Standing Devices: An Exploratory Study</brief_title>
  <official_title>Pediatric Powered Wheelchair Standing Devices: An Exploratory Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grand Valley State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Grand Valley State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For children who use a power wheelchair, a powered wheelchair standing device (PWSD) may be&#xD;
      considered for daily use. A PWSD allows a child to electronically move between sitting and&#xD;
      standing and can be driven in either position. Existing published PWSD research in pediatrics&#xD;
      is limited to boys with Duchenne muscular dystrophy (DMD).(1, 2) While these studies provide&#xD;
      some insights into PWSD use in boys with DMD, they do not reflect PWSD use in children with&#xD;
      other conditions. The purpose of this exploratory study is to determine the feasibility of a&#xD;
      research protocol exploring use of a PWSD in children who have neurodevelopmental conditions&#xD;
      other than DMD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participation in children</measure>
    <time_frame>2 years</time_frame>
    <description>Does using a PWSD increase participation in children who have neurodevelopmental conditions other than DMD?</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parental/caregiver perceptions</measure>
    <time_frame>2 years</time_frame>
    <description>Does using a PWSD influence parental/caregiver perceptions of their child's emotional/behavioral status?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Children's perceptions</measure>
    <time_frame>2 years</time_frame>
    <description>For children who are able to respond to questions and participate in an interview using either verbal or augmented communication, does using a PWSD influence their own perceptions of their emotional/behavioral status?</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Cerebral Palsy</condition>
  <condition>Spinal Muscular Atrophy</condition>
  <condition>Spinal Cord Injuries</condition>
  <condition>Spina Bifida</condition>
  <condition>Development Delay</condition>
  <condition>Genetic Disease</condition>
  <arm_group>
    <arm_group_label>Power Wheelchair Standing Device User</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Power Wheelchair Standing Device</intervention_name>
    <description>A power wheelchair standing device is a power wheelchair that allows a child to electronically move between sitting and standing. It can be driven in either position. The Permobil F5 Corpus VS is the specific power wheelchair standing device to be used in this study.</description>
    <arm_group_label>Power Wheelchair Standing Device User</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Is 5-17 years of age. NOTE: Participants must be under 18 for the duration of the&#xD;
             study.&#xD;
&#xD;
          2. Diagnosed with a neurodevelopmental condition resulting in an inability to&#xD;
             functionally ambulate.&#xD;
&#xD;
          3. Can safely assume and maintain a supported standing position&#xD;
&#xD;
          4. Has sufficient upper extremity and function to safely use a PWSD&#xD;
&#xD;
          5. Can communicate pain or discomfort through verbalization, vocalization, use of&#xD;
             augmented communication, etc.&#xD;
&#xD;
          6. Can safely use the PWSD in areas of their home&#xD;
&#xD;
          7. Has at least one parent/caregiver who is able to converse in English and actively&#xD;
             participate in a device-use education provided in English&#xD;
&#xD;
          8. The PerMobil PWSD can be set up to meet the child's specific needs&#xD;
&#xD;
          9. Medical Clearance to trial the PWSD&#xD;
&#xD;
         10. Participants must reside in Michigan&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Has a diagnosis of Duchenne muscular dystrophy.&#xD;
&#xD;
          2. Any reason that it would not be safe for the child to use a PWSD&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lisa K. Kenyon, PT, PhD</last_name>
    <phone>616-331-5653</phone>
    <email>kenyonli@gvsu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Grand Valley State University</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa K. Kenyon, PT, PhD</last_name>
      <phone>616-331-5653</phone>
      <email>kenyonli@gvsu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 1, 2021</study_first_submitted>
  <study_first_submitted_qc>November 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Grand Valley State University</investigator_affiliation>
    <investigator_full_name>Lisa Kenyon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
    <mesh_term>Spinal Dysraphism</mesh_term>
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The research team may share research data related to study outcomes from this study with other investigators. If this occurs, the data will not contain identifiable data.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>2 years</ipd_time_frame>
    <ipd_access_criteria>Contact PI</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

